Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Fuchs, DN; Fuith, LC; Hausen, A; Hetzel, H; Reibnegger, GJ; Werner, ER; Wachter, H.
Preactivated T cells in cancer patients with poor prognosis.
CANCER DETECTION PREV. 1988; 12(1-6): 97-103.
Web of Science
PubMed
- Co-Autor*innen der Med Uni Graz
- Reibnegger Gilbert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- We investigated the outcome of disease in correlation with pretherapeutic urinary neopterin levels in 161 patients suffering from cervical carcinoma and 51 patients suffering from ovarian cancer. Neopterin is produced by human macrophages upon stimulation with interferon gamma and is therefore a measure for activated T cells. In both types of cancer, neopterin levels before therapy were of predictive significance. Patients with pretherapeutically high neopterin levels were more likely to die earlier. Even 12-18 months after the start of therapy this effect was significant. The data indicate that primary events in the immune surveillance are intact in those patients but effector mechanisms might be diminished. Persistent activation of cell-mediated immunity appears to be unfavorable in cancer patients.
- Find related publications in this database (using NLM MeSH Indexing)
- Biopterin - analogs and derivatives
- Female - analogs and derivatives
- Humans - analogs and derivatives
- Immunity, Cellular - analogs and derivatives
- Interferon Type II - pharmacology
- Lymphocyte Activation - pharmacology
- Macrophages - drug effects
- Neopterin - drug effects
- Ovarian Neoplasms - immunology
- Prognosis - immunology
- T-Lymphocytes - immunology
- Uterine Cervical Neoplasms - immunology